Nasal melatonin gels using pluronic PF-127 for chronobiological treatment of sleep disorder

Indian Journal of Biotechnology

Volumn 3, Issue 3, 2004, Pages 369-377

  Pisal, S S ^a   Reddy, P ^a   Paradkar, A R ^a   Mahadik, K R ^a   Kadam, S S ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Chronobiological release; Melatonin; Nasal; Pluronic gels; Sleep pattern

Indexed keywords

MACROGOL; MACROGOL 15000; MACROGOL 400; MELATONIN; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; CHRONOBIOLOGY; CHRONOPHARMACOLOGY; CORRELATION ANALYSIS; DIFFUSION; DRUG FORMULATION; DRUG SYNTHESIS; ELECTROENCEPHALOGRAM; GEL; HIGH TEMPERATURE; HUMAN; HUMAN EXPERIMENT; MELTING POINT; MICELLE; NORMAL HUMAN; SLEEP DISORDER; SLEEP PATTERN; TABLET FORMULATION;

OVIS ARIES;

EID: 3943062309     PISSN: 09725849     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Morgan S X, Melatonin receptors: Localization, molecular pharmacology and physiological significance, Neurochem Int, 24 (1994) 101-105.
2. Arendt J & Deacon S, Treatment of circadian rhythm disorders: Melatonin, Chronobiol Int, 14 (1997) 185-204.
3. Lerner A B, Isolation of melatonin, the pineal gland factor that lightens melanocytes, J Am Chem Soc, 80 (1958) 2587-2592.
4. Elizabeth A L & Howard B M, Pharmacokinetics of melatonin in man: First pass hepatic metabolism, J Clin Endocrinol & Metab, 61 (1985) 1214-1216.
5. Andrea S, Patricia S, Johnson R, Tschopp A & Steffen R, Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag, Chronobiol Int, 15 (1998) 655-666.
6. Sandyk R, Anninos P A & Tsagas N, Magnetic field and seasonality of affective illness: Implications for therapy, Int J Neurosci, 58 (1991) 261-267.
7. Reiter R J, Oh C S & Fujimori O, Melatonin: Its intracellular and genomic actions, Trends Endocrinol & Metab, 7 (1996) 22-27.
8. Susan M W & Manuel P D, Role of melatonin in health and disease, Clin Endocrinol, 42 (1995) 221-234.
9. Nava Z, Development of melatonin based formulation for the treatment of insomnia in the elderly, Drug Dev Res, 50 (2000) 226-234.
10. Lewy A J, Ahmed S, Latham J J M & Sack R L, Melatonin shifts human circadian rhythms according to a phase response curve, Chronobiol Int, 9 (1992) 380-392.
11. Beom J L, Seung G R & Jing H C, Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin, Drug Dev Ind Pharm, 25 (1999) 493-501.
12. Benes L, Claustrat B, Horriere F, Geoffriau M, Konsil J et al, Transmucosal, oral controlled-release and drug administration in human subjects: A crossover study with melatonin, J Pharm Sci, 86 (1997) 1115-1119.
13. Beom J L, Keith A P, Ayres J W & Sack R L, Development and characterization of an oral controlled release delivery system for melatonin, Drug Dev Ind Pharm, 22 (1996) 269-274.
14. Lewy A J & Sack R L, Human melatonin production decreases with age, J Pineal Res, 3 (1986) 379-388.
15. Lewy A J & Sack R L, Exogenous melatonin's phase-shifting effects on the endogenous melatonin profile in sighted humans: A brief review and critique of the literature, J Biol Rhythms, 12 (1997) 588-594.
16. Merkus F W H M, Nasal melatonin composition, US Pat 6007834 (to Kasterlee, BE), 26 March 1998.
17. Chein Y W & Su K S E, Nasal systemic drug delivery (Marcel Dekker, New York) 1989, 2-10.
18. Pontiroli A, Alberetto M & Pozza G, Intranasal calcitonin and plasma calcium concentration in normal subjects, Br Med J, 290 (1985) 1390-1395.
19. Farraj N F, Johansen B R, Davis S S & Illum L, Nasal administration of insulin using bioadhesive microspheres as a delivery system, J Controlled Release, 13 (1990) 253-261.
20. Bjork E & Edman P, Degradable starch microspheres as nasal delivery systems for insulin, Int J Pharm, 47 (1988) 233-238.
21. Vyas S P, Talwar N & Jain N K, An erythrocyte based bioadhesive system for nasal delivery of propranolol, J Controlled Release, 23 (1993) 231-237.
22. Schmolka I R, Polymers for controlled drug delivery (CRC Press, Boca Raton) 1991, 189-194.
23. Chen C P C & Frank S G, In vitro release of lidocaine from pluronic F-127, Int J Pharm, 8 (1981) 89-99.
24. Miyazaki S, Yokonchi C & Nakamura T, Pluronic F127 gels as a novel vehicle for rectal administration of indomethacin, Chem Pharm Bull, 34 (1986) 1801-1808.
25. Desai S D & Blanchard J, In vitro evaluation of pluroinc F-127 based controlled release ocular delivery systems for pilocarpine, J Pharm Sci, 87 (1998) 226-230.
26. Schmolka I R, Artificial skin I. Preparation and properties of pluronic F-127 gels for the treatment of burns, J Biomed Mater Res, 6 (1972) 571-577.
27. Miller S C & Donovan M D, Effect of poloxamer 407 gels on the miotic activity of pilocarpine nitrate in rabbits, Int J Pharm, 12 (1982)147-152.
28. Pisal S S, Studies on nasal drug delivery of some drugs, Ph D Thesis, University of Pune, Pune, 2002.
29. Julraht K & Keith A P, Transmucosal administration of melatonin, Drug Dev Ind Pharm, 21 (1995) 1337-1348.
30. Yong C S, Choi J S, Quan Q Z, Rhee J D, Kim C K et al, Effect of sodium chloride on gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium, Int J Pharm, 226 (2001) 195-205.
31. Richard P, Biopack Systems Inc (Manual No.PL 3.03-ML 3.03), Santa Barbara, CA, L3, 1998.
32. Miyazaki S, Takenchi S, Vokouchi C & Takada M, Pluronic F-127 gels as a vehicle for topical administration of anticancer agents, Chem Pharm Bull, 32 (1984) 4205-4208.
33. Morikawa S, Matsuzawa A & Isowa K, Enhancement of therapeutic effects of recombinant interleukin-2 on a transplantable rat fibrosarcoma by the use of a sustained release vehicle - Pluronic gel, Cancer Res, 47 (1987) 37-43.
34. Brown W & Schillen K, Micelle and gel formation in a pluronic triblock co-polymer in water. Dynamic light scattering and oscillatory shear measurements, J Phys Chem, 95 (1991) 1850-1858.
35. Rassing J & Attwood D, Ultrasonic velocity and light scattering studies on the polyoxyethylene- polyoxypropylene copolymer Pluronic F-127 in aqueous solution, Int J Pharm, 13 (1983) 47-55.
36. Mortensen K & Talman Y, The micelle formation and gelation of P85 using small angle neutron scattering, Macromol, 28 (1995) 8829-8832.
37. Vadnere M, Amidon G & Haslam J L, Thermodynamic studies on the gel-sol transition of some pluronic polyols, Int J Pharm, 22 (1984) 207-218.
38. Gilbert J C, Washington C & Hadgraft J, The behaviour of pluronic F-127 in aqueous solution studies using fluorescent probes, Int J Pharm, 40 (1987) 93-99.
39. Prudhomme R K, Guangewei Wu & Scheidev D K, Structure and rheology study of poly (oxyethylene-oxypropylene-oxyethylene) aqueous solution, Langmuir, 12 (1996) 4651-4659.
40. Reddy P, Studies on nasal gels of malatonin, M Pharm Thesis, Bharati Vidyapeeth Deemed University, Pune, 2002.
41. Gilbert J C, Hadgraft J, Bye A & Brookes L G, Drug release from pluronic F-127 gels, Int J Pharm, 32 (1986) 223-228.
42. Andega S, Kanikkannan N & Singh M, Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin, J Controlled Release, 77 (2001) 17-25.
43. Hirai S, Yashike T & Mima H, Mechanism for the enhancement of the nasal absorption of insulin by surfactants, Int J Pharm, 9 (1978) 173-178.
44. Tortora G J & Grabowski S R, Principles of anatomy and physiology (Harper Collins, New York) 1996, 421-427.